7CQ1

Solution structure of the C-terminal domain of Mycobacterium Tuberculosis ribosome maturation factor protein RimM

7CQ1 の概要

• エントリーDOI: 10.2210/pdb7cq1/pdb
• NMR情報: BMRB: 36368
• 分子名称: Ribosome maturation factor RimM (1 entity in total)
• 機能のキーワード: ribosome maturation, 30s subunit, protein binding
• 由来する生物種: Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 9293.42

構造登録者

Zhang, H.,Lin, D. (登録日: 2020-08-08, 公開日: 2021-03-31, 最終更新日: 2024-05-15)

主引用文献

Zhang, H.,Zhou, Q.,Guo, C.,Feng, L.,Wang, H.,Liao, X.,Lin, D.
Structural Basis for the C-Terminal Domain of Mycobacterium tuberculosis Ribosome Maturation Factor RimM to Bind Ribosomal Protein S19.
Biomolecules, 11:-, 2021

PubMed Abstract: Multidrug-resistant tuberculosis (TB) is a serious threat to public health, calling for the development of new anti-TB drugs. Chaperon protein RimM, involved in the assembly of ribosomal protein S19 into 30S ribosomal subunit during ribosome maturation, is a potential drug target for TB treatment. The C-terminal domain (CTD) of RimM is primarily responsible for binding S19. However, both the CTD structure of RimM from (RimM) and the molecular mechanisms underlying RimM binding S19 remain elusive. Here, we report the solution structure, dynamics features of RimM, and its interaction with S19. RimM has a rigid hydrophobic core comprised of a relatively conservative six-strand β-barrel, tailed with a short α-helix and interspersed with flexible loops. Using several biophysical techniques including surface plasmon resonance (SPR) affinity assays, nuclear magnetic resonance (NMR) assays, and molecular docking, we established a structural model of the RimM-S19 complex and indicated that the β4-β5 loop and two nonconserved key residues (D105 and H129) significantly contributed to the unique pattern of RimM binding S19, which might be implicated in a form of orthogonality for species-dependent RimM-S19 interaction. Our study provides the structural basis for RimM binding S19 and is beneficial to the further exploration of RimM as a potential target for the development of new anti-TB drugs.

PubMed: 33919647
DOI: 10.3390/biom11040597

実験手法

SOLUTION NMR